Skip to main content
. Author manuscript; available in PMC: 2009 Oct 1.
Published in final edited form as: Ann Oncol. 2008 May 22;19(10):1802–1809. doi: 10.1093/annonc/mdn363

Table 3.

Mean (SD) Pharmacokinetic Parameters of Trabectedin

Dose Cohort, mg/m2
0.4
(n = 3)
0.6
(n = 3)
0.75*
(n = 2)
0.9
(n = 3)
1.1
(n = 9)
1.3
(n = 5)
Tmax, h 2.40 1.93 1.50, 2.83 (0.0) 1.71 (0.93) 2.60
(0.77) (0.78) 1.50 (0.62)
Cmax, ng/mL 2.30 3.47 4.76, 6.24 7.87 (2.04) 7.71
(0.46) (0.51) 3.43 (0.69) (1.66)
AUC, 9.86 19.2 28.6, 37.6 53.5 53.2
ng•h/mL (1.57) (8.34) 13.1 (2.08) (22.2) (10.8)
CL, L/h 74.5 70.9 51.2, 45.5 40.8 48.4
(8.88) (29.4) 78.2 (6.49) (14.8) (10.7)
Vss, L 744 1595 1915, 2395 2643 3093
(453) (1075) 1141 (1103) (1219) (411)
t½, h 19.6 43.1 54.4, 75.6 93.0 83.2
(5.43) (37.4) 27.0 (15.7) (36.2) (8.25)

Abbreviations: SD, standard deviation; Tmax, time to peak plasma concentration; Cmax, peak plasma concentration; AUC, area under plasma concentration-time curve; CL, clearance; Vss, volume of distribution at steady state; t½, half-life.

*

Individual parameter values provided.

From 0 to infinity.

N = 8.